Oral white lesions: pitfalls of diagnosis.

Med J Aust

Christchurch Hospital, Christchurch, New Zealand.

Published: March 2009

AI Article Synopsis

  • General practitioners are usually the first to examine oral white lesions, which can indicate various health issues, some more serious than others.
  • Different clinical features can overlap between conditions, so thorough patient history and additional tests are essential for accurate diagnosis.
  • Leukoplakia is a key term referring to potentially premalignant white lesions, and patients with such lesions should be referred to specialists for proper management.

Article Abstract

General practitioners are often the first point of contact for patients with oral white lesions, which represent a wide spectrum of diagnoses of varying seriousness. Some clinical features are classical and others overlap between different diagnoses; they should be correlated with patient history, and sometimes other investigations, for diagnosis. Leukoplakia is a clinical term, and is a diagnosis of exclusion with no histopathological connotation. It has been redefined to describe a predominantly white lesion with premalignant potential. Patients with lesions that are potentially malignant should be referred to an oral medicine specialist or oral maxillofacial surgeon for systematic management.

Download full-text PDF

Source
http://dx.doi.org/10.5694/j.1326-5377.2009.tb02395.xDOI Listing

Publication Analysis

Top Keywords

oral white
8
white lesions
8
oral
4
lesions pitfalls
4
pitfalls diagnosis
4
diagnosis general
4
general practitioners
4
practitioners point
4
point contact
4
contact patients
4

Similar Publications

COVID-19 Vaccine Hesitancy Among Black Women in the US.

JAMA Netw Open

January 2025

Department of Management, Policy, and Community Health, School of Public Health, The University of Texas Health Science Center, Houston.

Importance: COVID-19 vaccine hesitancy among Black women is a critical public health concern, potentially exacerbating existing health disparities and impacting community-wide vaccination efforts.

Objective: To explore the factors associated with COVID-19 vaccine hesitancy among Black women in the US and identify the specific concerns and experiences shaping hesitant attitudes toward vaccination.

Design, Setting, And Participants: Qualitative study using in-depth, semistructured interviews conducted virtually between June and November 2021.

View Article and Find Full Text PDF

Background: Apolipoprotein ε4 allele (APOE4) is the strongest genetic risk factor for late-onset Alzheimer's disease (AD) with females having higher risk than males. Compared with non-carriers, cognitively normal, middle-aged APOE4 carriers have lower cerebral blood flow (CBF) decades before clinical symptoms appear. Early intervention to protect CBF would be critical for APOE4 carriers to mitigate AD progression.

View Article and Find Full Text PDF

Background: Alzheimer's disease (AD) is a neurodegenerative disease characterized by progressive cognitive decline. APOE-ε4 has been identified as the most prevalent genetic risk factor for the early onset of AD, while ABCA7-80 (rs115550680) has been shown to have a stronger effect size than the APOE-ε4 allele and is associated with the development of late-onset of AD among African Americans. Although the efficiency of executive functions declines with age, some basic attentional functions and preserved knowledge may help mitigate the effects of aging on working memory.

View Article and Find Full Text PDF

Background: The Southern Illinois University Longitudinal Cognitive Aging Study (SIU LCAS) is a community-based, longitudinal cohort study initiated in 1984. LCAS was initially designed to improve the sensitivity of neuropsychological testing to diagnose mild cognitive impairment (MCI) and dementia in individuals residing in central and southern Illinois.

Method: Participants are recruited from the community via newspaper advertisement, word-of-mouth, and community presentations.

View Article and Find Full Text PDF

Background: Global health is increasingly burdened by oral diseases (ODs) affecting 3.9 billion people, and Alzheimer's disease with related dementias (AD/ADRD), impacting 46.8 million globally.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!